Healthcare company CVS Health Corporation (NYSE: CVS) is all set to report earnings next week, with Wall Street expecting a mixed outcome.
What to look for when CVS Health (CVS) reports Q3 earnings
Categories
Healthcare Services
CVS Health to report Q2 2024 results on Wednesday. Here’s what to expect
Healthcare conglomerate CVS Health Corporation (NYSE: CVS) had a modest start to fiscal 2024, with sales and profit coming under pressure from
Earnings Summary: Organon reports financial results for Q1 2024
Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and adjusted earnings for the first quarter of 2024. First-quarter revenue
Earnings Preview: UnitedHealth (UNH) looks poised to deliver another strong quarter
After delivering a solid performance last year, UnitedHealth Group (NYSE: UNH) will be reporting first-quarter financial data next week. The healthcare conglomerate’s
PACS Group gears up for $400 million IPO. Here’s all you need to know
After a slow start to the year, the IPO market is witnessing a rush of tech and healthcare companies seeking to go
Walgreens Boots Alliance set to report earnings next week. Here’s what to expect
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring
CVS Health Q4 2023 adj. earnings rise on higher revenues; guides FY24
Healthcare conglomerate CVS Health Corporation (NYSE: CVS) announced fourth-quarter 2023 results, reporting higher revenues and adjusted earnings. December quarter adjusted profit increased
Earnings Summary: Highlights of Centene Corp’s Q4 2023 financial results
Healthcare service provider Centene Corporation (NYSE: CNC) on Tuesday announced fourth-quarter 2023 results, reporting an increase in revenues and a fall in
Earnings Summary: Everything you need to know about IDEXX’s Q4 2023 report
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a provider of pet healthcare innovation, on Monday reported higher revenues and net income for the fourth
Earnings Summary: A snapshot of McKesson Corporation’s Q1 2024 report
McKesson Corporation (NYSE: MCK), a diversified healthcare service company that operates in partnership with biopharma companies, care providers, pharmacies, and governments, on
Intuitive Surgical (ISRG) reports higher Q2 revenues and earnings
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the second quarter of 2023, reporting higher revenues and adjusted
Bio Path Holdings Inc (BPTH) Q1 2023 Earnings Call Transcript
Bio Path Holdings Inc (NASDAQ:BPTH) Q1 2023 Earnings Call dated May. 12, 2023. Corporate Participants: Will O'Connor -- Managing Director Peter H. Nielsen -- Chairman, President,
BioLife Solutions Inc (BLFS) Q1 2023 Earnings Call Transcript
BioLife Solutions Inc (NASDAQ:BLFS) Q1 2023 Earnings Call dated May. 10, 2023. Corporate Participants: Troy Wichterman -- Chief Financial Officer Michael Rice -- Chairman & Chief
McKesson Corporation (MCK) Q4 2023 Earnings Call Transcript
McKesson Corporation (NYSE:MCK) Q4 2023 Earnings Call dated May. 08, 2023. Corporate Participants: Nicole Kramer -- Manager of Investor Relations Brian Tyler -- Chief Executive Officer
GoHealth Inc (GOCO) Q1 2023 Earnings Call Transcript
GoHealth Inc (NASDAQ:GOCO) Q1 2023 Earnings Call dated May. 08, 2023. Corporate Participants: John Shave -- Vice President of Investor Relations Vijay Kotte -- Chief Executive
Cigna Corporation (CI) Q1 2023 Earnings Call Transcript
Cigna Corporation (NYSE:CI) Q1 2023 Earnings Call dated May. 05, 2023. Corporate Participants: Ralph Giacobbe -- Senior Vice President & Head of Investor Relations
ImmunoGen Inc (IMGN) Q1 2023 Earnings Call Transcript
ImmunoGen Inc (NASDAQ:IMGN) Q1 2023 Earnings Call dated Apr. 28, 2023. Corporate Participants: Anabel Chan -- Head, Investor Relations Mark Enyedy -- President & Chief Executive
Edwards Lifesciences Corporation (EW) Q1 2023 Earnings Call Transcript
Edwards Lifesciences Corporation (NYSE: EW) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Mark Wilterding -- Senior Vice President, Investor Relations and
Biogen Inc (BIIB) Q1 2023 Earnings Call Transcript
Biogen Inc (NASDAQ:BIIB) Q1 2023 Earnings Call dated Apr. 25, 2023. Corporate Participants: Chuck Triano -- Head of Investor Relations Christopher Viehbacher -- President and Chief
Abbott Laboratories (ABT) Q1 2023 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q1 2023 earnings call dated Apr. 19, 2023 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing and Acquisitions
Intuitive Surgical Inc (ISRG) Q1 2023 Earnings Call Transcript
Intuitive Surgical Inc (NASDAQ:ISRG) Q1 2023 Earnings Call dated Apr. 18, 2023. Corporate Participants: Brian King -- Treasurer and Head of Investor Relations Gary